Sygnis

Sygnis Cost of Goods Sold

The Cost of Goods Sold (COGS) of Sygnis (SYG.WA) as of Nov 6, 2026 is 3.09 M PLN. In the previous year, Cost of Goods Sold (COGS) was 4.72 M PLN — a change of -34.50% (lower).

Cost of Goods Sold

3.09 MPLN

YoY

-34.50%

Last updated:

Cost of Goods Sold (COGS) of Sygnis is 2025 3.09 M PLN. Cost of Goods Sold (COGS) of Sygnis was 2024 4.72 M PLN. It decreases by -34.50% lower compared to the previous year.

The Sygnis Cost of Goods Sold history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cost of Goods Sold
Date
Cost of Goods Sold
Jan 1, 2017
788,300.00 PLN
Jan 1, 2018
873,100.00 PLN
Jan 1, 2020
885,044.20 PLN
Jan 1, 2021
1.59 M PLN
Jan 1, 2022
16.91 M PLN
Jan 1, 2023
15.28 M PLN
Jan 1, 2024
4.72 M PLN
Jan 1, 2025
3.09 M PLN
The Sygnis Cost of Goods Sold history
YEARCost of Goods SoldYoY
3.09 MPLN-34.50%
4.72 MPLN-69.13%
15.28 MPLN-9.66%
16.91 MPLN+964.28%
1.59 MPLN+79.56%
885,044.20PLN+1.37%
873,100.00PLN+10.76%
788,300.00PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sygnis Stock analysis

What does Sygnis do? Sygnis SA generates revenue through its research and development services across four segments: Bioconvergence, Nanotechnology, Power Engineering, and New Incremental Technologies. Bioconvergence focuses on bioprinting organs to prevent transplant shortages and creating bionic models for drug testing. Nanotechnology applies photoelectron spectroscopy and atomic force microscopy solutions to consumer products. Power Engineering develops energy storage methods for renewable energy sources. New Incremental Technologies specializes in 3D printing solutions. The company collaborates with over 85 specialists including physicists, mechatronics, chemists, engineers, designers, and sociologists to execute multiple projects. Clients for Sygnis SA's services include organizations requiring advanced research in bioprinting, nanotechnology applications, energy storage, and 3D printing solutions. The firm serves sectors such as healthcare, technology, and renewable energy through its specialized R&D segments. Projects are executed by its team of 85 specialists working across the four business areas. Sygnis SA's revenue streams are derived from contracts with clients seeking innovative R&D in organ bioprinting, bionic drug testing models, photoelectron spectroscopy applications, energy storage systems, and 3D printing technologies. The company's business model relies on delivering specialized research services to clients across healthcare, technology, and renewable energy sectors through its four distinct R&D segments. Sygnis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sygnis stock

Cost of Goods Sold (COGS) of Sygnis is 3.09 M PLN in 2025.

Cost of Goods Sold (COGS) of Sygnis changed from 4.72 M PLN to 3.09 M PLN, representing a -34.50% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cost of Goods Sold (COGS) Sygnis since 2006 – with annual values, charts, and detailed analysis.

COGS represents the direct costs attributable to the production of goods sold. It includes material and labor costs directly tied to the product.

Cost of Goods Sold (COGS)'s PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Cost of Goods Sold (COGS)'s Sygnis historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Sygnis

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Sygnis